• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Discordance between K-ras mutations in bone marrow micrometastases and the primary tumor in colorectal cancer.

作者信息

Tórtola S, Steinert R, Hantschick M, Peinado M A, Gastinger I, Stosiek P, Lippert H, Schlegel W, Reymond M A

机构信息

Fondation Pour Recherches Médicales, Geneva, Switzerland.

出版信息

J Clin Oncol. 2001 Jun 1;19(11):2837-43. doi: 10.1200/JCO.2001.19.11.2837.

DOI:10.1200/JCO.2001.19.11.2837
PMID:11387355
Abstract

PURPOSE

To study bone marrow micrometastases from colorectal cancer patients for the presence of K-ras mutations and to compare their genotype with that of the corresponding primary tumor.

PATIENTS AND METHODS

Bilateral iliac crest aspiration was performed in 51 patients undergoing surgery for colorectal cancer, and bone marrow micrometastases were detected by immunohistochemistry. The presence of K-ras mutations was determined by single-strand conformation polymorphism analysis on both primary tumors and paired bone marrow samples and was confirmed by sequencing.

RESULTS

In six patients with primary tumor mutations, it was possible to amplify a mutated K-ras gene also from the bone marrow sample. In three of those patients the pattern of K-ras mutations differed between both samples, in two patients the mutation was identical between the bone marrow and its primary tumor, and in one patient the same mutation plus a different one were found. Fifteen of 17 K-ras mutations found in primary tumors were located in codon 12, whereas in bone marrow, five of seven mutations were found in codon 13 (P =.003).

CONCLUSION

Our results demonstrate that, at least for K-ras mutations, disseminated epithelial cells are not always clonal with the primary tumor and they question the malignant genotype of bone marrow micrometastases. They also indicate that different tumoral clones may be circulating simultaneously or sequentially in the same patient. Analysis of the type of mutations suggests that cell dissemination might be an early event in colorectal carcinogenesis.

摘要

相似文献

1
Discordance between K-ras mutations in bone marrow micrometastases and the primary tumor in colorectal cancer.
J Clin Oncol. 2001 Jun 1;19(11):2837-43. doi: 10.1200/JCO.2001.19.11.2837.
2
K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.K-ras基因第12和13密码子突变与结直肠癌患者肿瘤细胞播散的不同模式相关。
Int J Oncol. 2004 Jun;24(6):1537-44.
3
Disseminated colorectal tumor cells in organs prone to metastasis detected by new double enriched nested-PCR in comparison with recognized assays.新的双重富集巢式 PCR 检测到易转移器官中的播散性结直肠肿瘤细胞,与公认的检测方法相比。
Oncol Rep. 2011 May;25(5):1421-9. doi: 10.3892/or.2011.1203. Epub 2011 Mar 2.
4
K-ras mutational analysis of polyclonal colorectal cancers identifies uniclonal circulating tumor cells.多克隆结直肠癌的K-ras突变分析鉴定出单克隆循环肿瘤细胞。
Am Surg. 2001 Aug;67(8):802-5.
5
Detection of isolated tumor cells by polymerase chain reaction-restriction fragment length polymorphism for K-ras mutations in tissue samples of 199 colorectal cancer patients.采用聚合酶链反应-限制性片段长度多态性方法检测199例结直肠癌患者组织样本中K-ras突变的孤立肿瘤细胞。
Clin Cancer Res. 2004 Jan 15;10(2):641-50. doi: 10.1158/1078-0432.ccr-1355-02.
6
The balanced induction of K-ras codon 12 and 13 mutations in mucosa differs from their ratio in neoplastic tissues.黏膜中K-ras密码子12和13突变的平衡诱导与其在肿瘤组织中的比例不同。
Int J Oncol. 2006 Oct;29(4):957-64.
7
Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype.K-ras基因第13密码子的特定突变可预测结直肠癌患者的临床结局,而K-ras基因第12密码子的突变与黏液组织学类型相关。
Ann Oncol. 2002 Sep;13(9):1438-46. doi: 10.1093/annonc/mdf226.
8
Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors.结直肠结节聚集性肿瘤中K-ras密码子12突变及p53过表达分析
J Gastroenterol Hepatol. 2000 Oct;15(10):1151-7. doi: 10.1046/j.1440-1746.2000.02280.x.
9
APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.结直肠癌患者中APC、K-ras和p53基因突变:与临床病理特征及术后监测的相关性
Am Surg. 2005 Apr;71(4):336-43.
10
[Screening for K-ras mutations in colorectal and lung cancers by using a novel real-time PCR with ADx-K-ras kit and Sanger DNA sequencing].使用新型实时PCR结合ADx-K-ras试剂盒及桑格DNA测序法筛查结直肠癌和肺癌中的K-ras突变
Zhonghua Bing Li Xue Za Zhi. 2010 Nov;39(11):757-61.

引用本文的文献

1
Biomarker concordance between primary colorectal cancer and its metastases.原发结直肠癌及其转移灶的生物标志物一致性。
EBioMedicine. 2019 Feb;40:363-374. doi: 10.1016/j.ebiom.2019.01.050. Epub 2019 Feb 4.
2
Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine?结直肠癌的异质性:对个体化医学的挑战?
Int J Mol Sci. 2018 Nov 23;19(12):3733. doi: 10.3390/ijms19123733.
3
Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case report.直肠癌再活检对治疗策略决策的益处:一例报告
Oncol Lett. 2017 Sep;14(3):3697-3700. doi: 10.3892/ol.2017.6601. Epub 2017 Jul 18.
4
May CTC technologies promote better cancer management?循环肿瘤细胞(CTC)技术能否促进更好的癌症管理?
EPMA J. 2015 Jan 22;6(1):1. doi: 10.1186/s13167-014-0023-x. eCollection 2015.
5
Molecular biomarkers for the detection of metastatic colorectal cancer cells.用于检测转移性结肠癌细胞的分子生物标志物。
World J Gastroenterol. 2014 Jul 21;20(27):8928-38. doi: 10.3748/wjg.v20.i27.8928.
6
Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow.乳腺癌循环肿瘤细胞和转移灶中PIK3CA的单细胞突变分析揭示了骨髓来源的培养播散肿瘤细胞中的异质性、不一致性和突变持续性。
BMC Cancer. 2014 Jun 19;14:456. doi: 10.1186/1471-2407-14-456.
7
Comparison of KRAS/BRAF mutations between primary tumors and serum in colorectal cancer: Biological and clinical implications.结直肠癌原发肿瘤与血清中KRAS/BRAF突变的比较:生物学及临床意义
Oncol Lett. 2013 Jan;5(1):249-254. doi: 10.3892/ol.2012.963. Epub 2012 Oct 10.
8
Biology and significance of circulating and disseminated tumour cells in colorectal cancer.循环肿瘤细胞和结直肠癌中播散肿瘤细胞的生物学特性及其意义。
Langenbecks Arch Surg. 2012 Apr;397(4):535-42. doi: 10.1007/s00423-012-0917-9. Epub 2012 Feb 15.
9
Concordance of predictive markers for EGFR inhibitors in primary tumors and metastases in colorectal cancer: a review.探讨结直肠癌原发灶和转移灶中表皮生长因子受体抑制剂预测标志物的一致性:综述。
Oncologist. 2011;16(9):1239-49. doi: 10.1634/theoncologist.2011-0024. Epub 2011 Jul 8.
10
Heterogeneous distribution of K-ras mutations in primary colon carcinomas: implications for EGFR-directed therapy.原发性结肠癌中 K-ras 突变的异质性分布:对 EGFR 靶向治疗的影响。
Int J Colorectal Dis. 2011 Oct;26(10):1271-7. doi: 10.1007/s00384-011-1233-5. Epub 2011 May 15.